Literature DB >> 10487414

Intractable hypercalcemia due to a metastatic carcinoid secreting parathyroid hormone-related peptide and interleukin-6: response to octreotide.

M Barhoum1, L Hutchins, V A Fonseca.   

Abstract

We describe a patient with a malignant carcinoid tumor who presented with severe, intractable hypercalcemia that would not respond to conventional therapy with fluids and pamidronate. His plasma concentrations of parathyroid-hormone-related peptide (PTHrP) and interleukin-6 (IL-6) were elevated. The patient was treated with subcutaneous injections of octreotide with a good response, resulting in normocalcemia. Plasma PTHrP and IL-6 fell with the octreotide but remained elevated above the upper limit of normal. We conclude that although rare, hypercalcemia may be associated with carcinoid tumors and may be mediated through the secretion of cytokines and or PTHrP. Treatment with octreotide may be effective in treating hypercalcemia in such patients.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10487414     DOI: 10.1097/00000441-199909000-00019

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  4 in total

Review 1.  Somatostatin analog therapy in treatment of gastrointestinal disorders and tumors.

Authors:  Wouter W de Herder; Steven W J Lamberts
Journal:  Endocrine       Date:  2003-04       Impact factor: 3.633

2.  Epidemiology of Large Bowel Carcinoid Tumors in the USA: A Population-Based National Study.

Authors:  Pooja Lal; Mohannad Abou Saleh; George Khoudari; Mohamed M Gad; Emad Mansoor; Gerard Isenberg; Gregory S Cooper
Journal:  Dig Dis Sci       Date:  2019-07-12       Impact factor: 3.199

3.  A Case of Carcinoid Tumor-Associated Hypercalcemia.

Authors:  Fadi Siyam; Obai Abdullah; Michael Gardner; Stephen Brietzke; James Sowers
Journal:  Cardiorenal Med       Date:  2012-01-26       Impact factor: 2.041

4.  A "false positive" octreoscan in ileal Crohn's disease.

Authors:  Alberto Fernandez; Olga Tabuenca; Angeles Peteiro
Journal:  World J Gastroenterol       Date:  2008-09-14       Impact factor: 5.742

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.